US2011184494A1PendingUtilityA1
Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerebral blood
Est. expiryMay 8, 2020(expired)· nominal 20-yr term from priority
A61B 5/4076A61N 1/0546A61B 5/026A61N 1/36082A61P 9/10A61N 1/326
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Apparatus for modifying a property of a brain of a patient is provided, including one or more electrodes ( 7 ), adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) ( 6 ) of the patient and a neural tract originating in or leading to the SPG. A control unit ( 8 ) is adapted to drive the one or more electrodes to apply a current to the site capable of inducing (a) an increase in permeability of a blood-brain barrier (BBB) of the patient, (b) a change in cerebral blood flow of the patient, and/or (c) an inhibition of parasympathetic activity of the SPG.
Claims
exact text as granted — not AI-modified1 . Apparatus for modifying a property of a brain of a patient, comprising:
one or more electrodes, adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
a control unit, adapted to drive the one or more electrodes to apply a current to the site capable of inducing an increase in permeability of a blood-brain barrier (BBB) of the patient.
2 . Apparatus for modifying a property of a brain of a patient, comprising:
one or more electrodes, adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
a control unit, adapted to drive the one or more electrodes to apply a current to the site capable of inducing an increase in cerebral blood flow of the patient.
3 . Apparatus for modifying a property of a brain of a patient, comprising:
one or more electrodes, adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
a control unit, adapted to drive the one or more electrodes to apply a current to the site capable of inducing a decrease in cerebral blood flow of the patient.
4 . Apparatus for modifying a property of a brain of a patient, comprising:
one or more electrodes, adapted to be applied to a site selected from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
a control unit, adapted to drive the one or more electrodes to apply a current to the site capable of inhibiting parasympathetic activity of the SPG.
5 . Apparatus according to any one of claims 1 - 4 , wherein the one or more electrodes are adapted for a period of implantation in the patient greater than about one month.
6 . Apparatus according to any one of claims 1 - 4 , and comprising a wire, adapted to connect the control unit to the one or more electrodes, wherein the control unit is adapted to drive the one or more electrodes from a position external to the patient.
7 . Apparatus according to any one of claims 1 - 4 , wherein the control unit is adapted to drive the one or more electrodes by wireless communication from a position external to the patient.
8 . Apparatus according to claim 7 , and comprising an electromagnetic coupling, adapted to couple the control unit and the one or more electrodes.
9 . Apparatus according to claim 7 , wherein the control unit is adapted to be in electro-optical communication with the one or more electrodes.
10 . Apparatus according to claim 7 , wherein the control unit is adapted to be in electro-acoustic communication with the one or more electrodes.
11 . Apparatus according to any one of claims 1 - 4 , wherein the control unit is adapted to be implanted in a nasal cavity of the patient.
12 . Apparatus according to any one of claims 1 - 4 , wherein the one or more electrodes are adapted to be implanted in a nasal cavity of the patient.
13 . Apparatus according to any one of claims 1 - 4 , wherein at least one of the one or more electrodes comprises a flexible electrode, adapted for insertion through a nostril of the patient and to extend therefrom to the site.
14 . Apparatus according to any one of claims 1 - 4 , and comprising at least one biosensor, adapted to measure a physiological parameter of the patient and to generate a signal responsive thereto, wherein the control unit is adapted to modify a parameter of the applied current responsive to the signal.
15 . Apparatus according to claim 14 , wherein the biosensor comprises a blood flow sensor.
16 . Apparatus according to claim 14 , wherein the biosensor comprises a temperature sensor.
17 . Apparatus according to claim 14 , wherein the biosensor comprises a chemical sensor.
18 . Apparatus according to claim 14 , wherein the biosensor comprises an ultrasound sensor.
19 . Apparatus according to claim 14 , wherein the biosensor comprises transcranial Doppler (TCD) apparatus.
20 . Apparatus according to claim 14 , wherein the biosensor comprises laser-Doppler apparatus.
21 . Apparatus according to claim 14 , wherein the biosensor comprises a systemic blood pressure sensor.
22 . Apparatus according to claim 14 , wherein the biosensor comprises an intracranial blood pressure sensor.
23 . Apparatus according to claim 22 , wherein the intracranial blood pressure sensor comprises a detecting element adapted to be fixed to a cerebral blood vessel, and wherein the control unit is adapted to analyze the signal to detect an indication of a change in blood pressure indicative of a clot.
24 . Apparatus according to claim 14 , wherein the biosensor comprises a kinetics sensor.
25 . Apparatus according to claim 24 , wherein the control unit is adapted to analyze the signal to detect an indication of a change in body disposition of the patient.
26 . Apparatus according to claim 14 , wherein the biosensor comprises an electroencephalographic (EEG) sensor.
27 . Apparatus according to claim 14 , wherein the biosensor comprises a blood vessel clot detector.
28 . Apparatus according to claim 1 , wherein the control unit is adapted to configure the current so as to facilitate uptake of a drug through the BBB when the permeability of the BBB is increased.
29 . Apparatus according to claim 2 , wherein the control unit is adapted to configure the current so as to increase a diameter of a blood vessel and allow an embolus that is located at a site in the blood vessel to move from the site in the blood vessel.
30 . Apparatus according to claim 2 , wherein the control unit is adapted to drive the one or more electrodes to apply the current responsive to an indication of stroke.
31 . Apparatus according to claim 4 , wherein the control unit is adapted to drive the one or more electrodes to apply the current responsive to an indication of migraine of the patient.
32 . A method for modifying a property of a brain of a patient, comprising:
selecting a site from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
applying a current to the site capable of inducing an increase in permeability of a blood-brain barrier (BBB) of the patient.
33 . A method for modifying a property of a brain of a patient, comprising:
selecting a site from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
applying a current to the site capable of inducing an increase in cerebral blood flow of the patient.
34 . A method for modifying a property of a brain of a patient, comprising:
selecting a site from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
applying a current to the site capable of inducing a decrease in cerebral blood flow of the patient.
35 . A method for modifying a property of a brain of a patient, comprising:
selecting a site from a group of sites consisting of: a sphenopalatine ganglion (SPG) of the patient and a neural tract originating in or leading to the SPG; and
applying a current to the site capable of inhibiting parasympathetic activity of the SPG.
36 . A method according to any one of claims 32 - 35 , wherein selecting the site comprises implanting an electrode at the site, designated to remain in the patient for a period greater than about one month.
37 . A method according to any one of claims 32 - 35 , wherein selecting the site comprises placing an electrode at the site, and wherein applying the current comprises communicating with the electrode by wired communication from a position external to the patient.
38 . A method according to any one of claims 32 - 35 , wherein selecting the site comprises placing an electrode at the site, and wherein applying the current comprises communicating with the electrode by wireless communication from a position external to the patient.
39 . A method according to claim 38 , wherein communicating comprises communicating via electromagnetic coupling.
40 . A method according to claim 38 , wherein communicating comprises communicating via electro-optical coupling.
41 . A method according to claim 38 , wherein communicating comprises communicating via electro-acoustic coupling.
42 . A method according to any one of claims 32 - 35 , wherein applying the current comprises implanting a control unit in a nasal cavity of the patient.
43 . A method according to any one of claims 32 - 35 , wherein applying the current comprises implanting one or more electrodes in a nasal cavity of the patient.
44 . A method according to claim 43 , wherein implanting comprises inserting a flexible electrode through a nostril of the patient.
45 . A method according to any one of claims 32 - 35 , and comprising sensing a physiological parameter of the patient and generating a signal responsive thereto, wherein applying the current comprises modifying a parameter of the applied current responsive to the signal.
46 . A method according to claim 45 , wherein sensing comprises sensing blood flow of the patient.
47 . A method according to claim 45 , wherein sensing comprises sensing a temperature of the patient.
48 . A method according to claim 45 , wherein sensing comprises sensing presence of a chemical.
49 . A method according to claim 45 , wherein sensing comprises detecting ultrasonic energy.
50 . A method according to claim 45 , wherein sensing comprises performing a transcranial Doppler (TCD) technique.
51 . A method according to claim 45 , wherein sensing comprises performing a laser-Doppler technique.
52 . A method according to claim 45 , wherein sensing comprises sensing systemic blood pressure of the patient.
53 . A method according to claim 45 , wherein sensing comprises sensing intracranial blood pressure of the patient.
54 . A method according to claim 53 , wherein sensing intracranial blood pressure fixing to a cerebral blood vessel a detecting element capable of generating the signal, and analyzing the signal to detect an indication of a change in blood pressure indicative of a clot.
55 . A method according to claim 45 , wherein sensing comprises sensing a kinetic disposition of the patient.
56 . A method according to claim 55 , wherein sensing the kinetic disposition comprises detecting an indication of a change in body disposition of the patient.
57 . A method according to claim 45 , wherein sensing comprises sensing electroencephalographic (EEG) data.
58 . A method according to claim 45 , wherein sensing comprises detecting presence of an embolus in a blood vessel of the patient.
59 . A method according to claim 32 , wherein applying the current comprises configuring the current so as to facilitate uptake of a drug through the BBB when the permeability of the BBB is increased.
60 . A method according to claim 33 , wherein applying the current comprises configuring the current so as to increase a diameter of a blood vessel and allow an embolus that is located at a site in the blood vessel to move from the site in the blood vessel.
61 . A method according to claim 33 , wherein applying the current comprises applying the current responsive to an indication of stroke.
62 . A method according to claim 35 , wherein applying the current comprises applying the current responsive to an indication of migraine of the patient.
63 . A method according to any one of claims 32 - 35 , wherein selecting the site comprises implanting an electrode at the site, designated to remain in the patient for a period less than about one week.
64 . Apparatus according to any one of claims 1 - 4 , wherein the one or more electrodes are adapted for a period of implantation in the patient less than about one week.
65 . Vascular apparatus, comprising:
a detecting element, adapted to be fixed to a blood vessel of a patient and to generate a signal responsive to energy coming from the blood vessel; and a control unit, adapted to analyze the signal so as to determine an indication of an embolus in the blood vessel.
66 . Apparatus according to claim 65 , wherein the detecting element comprises an energy transmitter and an energy receiver.
67 . Apparatus according to claim 66 , wherein the energy transmitter comprises an ultrasound transmitter.
68 . Apparatus according to claim 66 , wherein the energy transmitter comprises a transmitter of electromagnetic energy.
69 . A method for detecting, comprising:
fixing a detecting element to a blood vessel of a patient;
generate a signal responsive to energy coming from the blood vessel; and
analyzing the signal so as to determine an indication of an embolus in the blood vessel.
70 . A method according to claim 69 , wherein generating the signal comprises transmitting energy at the blood vessel.
71 . A method according to claim 70 , wherein generating the signal comprises transmitting ultrasound energy at the blood vessel.
72 . A method according to claim 70 , wherein generating the signal comprises transmitting electromagnetic energy at the blood vessel.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.